Pharmaceutical Analytical Testing Market Is Estimated To Witness High Growth Owing To Increasing Demand For Quality Control And Safety Of Pharmaceuticals
Market Overview:
The pharmaceutical analytical testing market involves the analysis of drug components, raw materials, and finished pharmaceutical products to ensure quality control and safety. This includes testing for potency, purity, dissolution, and identification. The need for accurate testing arises from the increasing complexity of pharmaceutical products and the strict regulatory requirements imposed by various drug regulatory bodies. Pharmaceutical analytical testing ensures that the drugs are safe, effective, and adhere to the required quality standards.
Market Key Trends:
One key trend driving the pharmaceutical analytical testing market is the increasing focus on quality control and safety in the pharmaceutical industry. With the rise in counterfeit drugs and the need for accurate drug analysis, pharmaceutical companies are investing in advanced analytical testing methods. This includes techniques such as High-Performance Liquid Chromatography (HPLC), Mass Spectrometry (MS), and Nuclear Magnetic Resonance (NMR) spectroscopy, among others. These advanced testing methods provide precise and reliable results, ensuring the quality and safety of pharmaceutical products.
The global Pharmaceutical Analytical Testing Market Size is estimated to be valued at US$ 7,137.91 Mn in 2022 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Overall, the pharmaceutical analytical testing market is expected to experience high growth in the coming years, driven by the increasing demand for quality control and safety in the pharmaceutical industry. Companies such as Steris PLC, West Pharmaceutical Services Inc., and Laboratory Testing Inc. are among the key players contributing to the market growth.
PEST Analysis:
Political: The political factors influencing the pharmaceutical analytical testing market include government regulations, policies, and initiatives related to drug safety and quality control. For example, the implementation of stringent regulations by regulatory authorities such as the FDA and EMA to ensure the safety and efficacy of pharmaceutical products.
Economic: The economic factors impacting the market include the overall economic stability and healthcare expenditure of countries. The increasing global healthcare expenditure and the growing focus on research and development activities in the pharmaceutical sector are expected to drive market growth.
Social: Social factors include changing demographics, healthcare awareness, and patient preferences. The increasing aging population and the rising prevalence of chronic diseases are creating a higher demand for pharmaceutical products, thereby driving the need for analytical testing.
Technological: The technological factors influencing the market include advancements in analytical testing techniques and equipment. The adoption of technologies such as high-performance liquid chromatography (HPLC) and mass spectrometry has enhanced the accuracy and efficiency of pharmaceutical analytical testing.
Key Takeaways:
The global pharmaceutical analytical testing market is expected to witness high growth, exhibiting a CAGR of 8.2% over the forecast period. The increasing demand for high-quality pharmaceutical products, rising prevalence of chronic diseases, and strict regulatory requirements are driving market growth.
North America is anticipated to be the fastest-growing and dominating region in the pharmaceutical analytical testing market. The presence of advanced healthcare infrastructure, robust regulatory framework, and significant investments in research and development activities are contributing to the market growth in this region.
Key players operating in the pharmaceutical analytical testing market include Steris PLC, West Pharmaceutical Services Inc., Boston Analytical, Intertek Pharmaceutical Services, Pace Analytical Services, Labcorp (Toxikon Inc.), SGS SA, Eurofins Scientific, and Laboratory Testing Inc., among others. These key players are focusing on strategies such as mergers and acquisitions, collaborations, and new product launches to strengthen their market position and expand their customer base.
Comments
0 comment